VITAPHARM 2026 wins 4 awards and welcomes executives from Medixa and Ejal40.
Romrawin Clinic participated in the VITAPHARM HIGH RECOGNITION AWARDS CEREMONY 2026 & Ejal40 GRAND LAUNCH, organized by VITAPHARM ASIA. The event included the official launch of the HA SKIN REBUILD program, along with the Partnership Awards ceremony, recognizing outstanding achievements in developing care standards and facilitating knowledge exchange in the field of aesthetic medicine.
On this occasion, Romrawin Clinic was recognized with four important awards, reflecting its commitment to developing medical knowledge, sharing professional experience, and continuously collaborating with partners to elevate the quality of care for patients.
The participating medical team included Dr. Akarawin Damrongwattanakin (License No. 52239), Dr. Arunee Thongakraniroj (License No. 40692), Dr. Thanisorn Thammalikitkul (License No. 10656), Dr. Cho-anchan Panya-ekavithu (License No. 49909), and Dr. Wanwimon Wannarak (License No. 27827), who were part of the knowledge exchange activities and award ceremony.
Romrawin Clinic and 4 awards of pride.
Romrawin Clinic proudly presents 4 awards at VITAPHARM 2026.
At the event, Romrawin Clinic had the honor of receiving a total of 4 awards, namely:
- The KOL Speaker Awards 2026 is presented to Dr. Akkarawin Damrongwattanapokin (License No. 52239).
- The KOL Trainer Awards 2026 is presented to Dr. Wanwimon Wanrak (Registration No. 27827).
- Prestige Excellence Award 2026
- Prestige Award 2026
Romrawin Clinic and 4 awards of pride.
These awards reflect the clinic's role in knowledge dissemination, supporting academic development, and maintaining ongoing collaboration with the medical network.
Romrawin Clinic continues to prioritize learning and developing its care standards to promote quality services, while regularly keeping abreast of new technologies and knowledge.
Welcome the executives from Medixa and Ejal40 on their special visit.
Welcome the executives from Medixa and Ejal40 on their special visit.
In addition to its award-winning achievements, Romrawin Clinic was also honored to welcome senior executives from Medixa and... Ejal40 This was a special visit by travelers from overseas to visit the clinic's medical team, the first such visit in Thailand.
The visiting executives included Mr. Stefano Emma, CEO of Medixa/Ejal40, and Mr. Vincenzo Mazzarella, a trainer for Ejal40.
This meeting marks another important opportunity to exchange knowledge and experiences in skincare, and reflects the collaboration between Romrawin Clinic and its international partners in continuously supporting the development of knowledge in aesthetic medicine.
Welcome the executives from Medixa and Ejal40 on their special visit.
What is the HA SKIN REBUILD program?
The HA SKIN REBUILD program is a skin care program within the HA SKIN REBUILD range that uses a high concentration of Hyaluronic Acid (HA) to help restore skin quality and support the skin's natural functions. It focuses on keeping the skin looking more hydrated, elastic, and smooth.
The concept of the HA SKIN REBUILD program is to care for overall skin quality by restoring skin structure and creating an optimal environment for skin cell function. Therefore, it has garnered attention in the field of aesthetic medicine for the care of skin that is beginning to change with age.
The launch of the HA SKIN REBUILD program at the VITAPHARM HIGH RECOGNITION AWARDS CEREMONY 2026 & Ejal40 GRAND LAUNCH marks another significant step in presenting knowledge and technology in skincare, while also providing an opportunity for medical professionals to exchange experiences and update their knowledge on international skincare trends.
Romrawin Clinic believes that developing knowledge coupled with exchanging experiences with networks both domestically and internationally is a key factor in elevating the standard of care for patients in all aspects.
The success of receiving four awards at the VITAPHARM HIGH RECOGNITION AWARDS CEREMONY 2026, along with welcoming executives from Medixa and Ejal40, reflects our commitment to continuous improvement and the application of acquired knowledge to provide appropriate care to patients, under a standard that prioritizes quality and unwavering progress.